(Circulation. 1999;100:1751-1756.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
From the Departments of Pharmacology and Therapeutics, McGill University (M.B., D.R.V., S.C.), and the Departments of Pediatrics and Pharmacology, Université de Montréal (P.A., P.H., A.-M.G., X.H., A.B., J.-C.F., S.C.), Montréal, Quebec, Canada; the Department of Ophthalmology, Wayne State University, Detroit, Mich (H.S.); and the Department of Pediatrics, University of California at San Francisco (R.I.C.).
Correspondence to Sylvain Chemtob, MD, PhD, FRCP(C), Research Center, Ste-Justine Hospital, 3175 Côte Ste-Catherine, Montréal, Québec, Canada, H3T 1C5. E-mail chemtobs{at}ere.umontreal.ca
BackgroundProstaglandin E2 (PGE2) is important in ductus arteriosus (DA) patency, but the types of functional PGE2 receptors (EP) in the developing DA are not known. We postulated that age-dependent alterations in EP and/or their subtypes may possibly contribute to the reduced responsiveness of the newborn DA to PGE2.
Methods and ResultsWe determined PGE2 receptor
subtypes by competition binding and immunoblot studies on
the DA of fetal (
75% and 90% gestation) and newborn (<45 minutes
old) pigs. We studied the effects of EP receptor stimulation on cAMP
signaling in vitro and on term newborn (<3 hours old) DA patency in
vivo. Fetal pig DA expressed EP2, EP3, and
EP4 receptors equivalently, but not EP1. In
neonatal DA, EP1, EP3, and EP4 were
undetectable, whereas EP2 density was similar in fetus and
newborn. Prostaglandin-induced changes in cAMP mirrored
binding data. 16,16-Dimethyl PGE2 and 11-deoxy
PGE1 (EP2/EP3/EP4
agonist) produced more cAMP in fetus than newborn, but butaprost
(selective EP2 agonist) caused similar cAMP increases in
both; EP3 and EP4 ligands (M&B28767 and
AH23848B, respectively) affected cAMP production only in fetus.
After birth, administration of butaprost alone was as effective as
11-deoxy PGE1 and 16,16-dimethyl PGE2 in
dilating DA in vivo.
ConclusionsThe data reveal fewer PGE2 receptors in the DA of the newborn than in that of the fetus; this may contribute to the decreased responsiveness of the DA to PGE2 in newborn. Because EP2 receptors seem to mediate the effects of PGE2 on the newborn DA, one may propose that a selective EP2 agonist may be preferred as a pharmacological agent to maintain DA patency in infants with certain congenital heart diseases.
Key Words: ductus arteriosus receptors prostaglandins pediatrics
This article has been cited by other articles:
![]() |
N. Waleh, H. Kajino, A. M. Marrache, D. Ginzinger, C. Roman, S. R. Seidner, T. J.M. Moss, J.-C. Fouron, A. Vazquez-Tello, S. Chemtob, et al. Prostaglandin E2--Mediated Relaxation of the Ductus Arteriosus: Effects of Gestational Age on G Protein-Coupled Receptor Expression, Signaling, and Vasomotor Control Circulation, October 19, 2004; 110(16): 2326 - 2332. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Thebaud, E. D. Michelakis, X.-C. Wu, R. Moudgil, M. Kuzyk, J. R.B. Dyck, G. Harry, K. Hashimoto, A. Haromy, I. Rebeyka, et al. Oxygen-Sensitive Kv Channel Gene Transfer Confers Oxygen Responsiveness to Preterm Rabbit and Remodeled Human Ductus Arteriosus: Implications for Infants With Patent Ductus Arteriosus Circulation, September 14, 2004; 110(11): 1372 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bouayad, J.-C. Fouron, X. Hou, M. Beauchamp, C. Quiniou, D. Abran, K. Peri, R. I. Clyman, D. R. Varma, and S. Chemtob Developmental regulation of prostaglandin E2 synthase in porcine ductus arteriosus Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2004; 286(5): R903 - R909. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Banu, J. A. Arosh, P. Chapdelaine, and M. A. Fortier Molecular cloning and spatio-temporal expression of the prostaglandin transporter: A basis for the action of prostaglandins in the bovine reproductive system PNAS, September 30, 2003; 100(20): 11747 - 11752. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Wright, D. Abran, M. Bhattacharya, X. Hou, S. G. Bernier, A. Bouayad, J.-C. Fouron, A. Vazquez-Tello, M. H. Beauchamp, R. I. Clyman, et al. Prostanoid receptors: ontogeny and implications in vascular physiology Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1343 - R1360. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bouayad, H. Kajino, N. Waleh, J.-C. Fouron, G. Andelfinger, D. R. Varma, A. Skoll, A. Vazquez, F. Gobeil Jr, R. I. Clyman, et al. Characterization of PGE2 receptors in fetal and newborn lamb ductus arteriosus Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2342 - H2349. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Loftin, D. B. Trivedi, H. F. Tiano, J. A. Clark, C. A. Lee, J. A. Epstein, S. G. Morham, M. D. Breyer, M. Nguyen, B. M. Hawkins, et al. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2 PNAS, January 23, 2001; (2001) 31573498. [Abstract] [Full Text] |
||||
![]() |
C. D. Loftin, D. B. Trivedi, H. F. Tiano, J. A. Clark, C. A. Lee, J. A. Epstein, S. G. Morham, M. D. Breyer, M. Nguyen, B. M. Hawkins, et al. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2 PNAS, January 30, 2001; 98(3): 1059 - 1064. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |